The promise of retinoids to fight against cancer
The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Abstract
Retinoids have a reputation for being both detrimental and beneficial: they are teratogens, but they also have tumour-suppressive capacity. Cell biology and genetics have significantly improved our understanding of the mechanisms that underlie the anti-proliferative action of retinoids. Recent elucidation of the pathways that are activated by retinoids will help us to exploit the beneficial aspects of this powerful class of compounds for cancer therapy and prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Apart from the well-known indications in hypovitaminosis and skin diseases, retinoids have been successfully used in treating cancer”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
In the citing paper
“The FDA has approved ATRA to treat cystic acne and several cancers, such as some lymphoma and leukemia”
From Vitamin A Update: Forms, Sources, Kinetics, Detection, Function, Deficiency, Therapeutic Use and Toxicity (2021) · cites this paper as [187]
Citations
Cites
The coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233 · cited 8×
“a | The t(15;17) chromosomal translocation generates the PML–RARα fusion protein that, in contrast to RARα, can efficiently dimerize or oligomerize, thereby recruiting multiple HDAC complexes and leading to ‘super-repression’ of target genes.”
BackgroundInfluentialKamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.-C., Heyman, R. A., Rose, D. W., Glass, C. K., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81118-6 · Cited by 2,150
Matthay, K. K., Villablanca, J. G., Seeger, R. C., Stram, D. O., Harris, R. E., Ramsay, N. K., Swift, P., Shimada, H., Black, C. T., Brodeur, G. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411601 · Cited by 1,898
ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics
McPherson, K. (2000) · BMJ · doi:10.1136/bmj.321.7261.624 · Cited by 1,570
Hong, W. K., Lippman, S. M., Itri, L. M., Karp, D. D., Lee, J. S., Byers, R. M., Schantz, S. P., Kramer, A. M., Lotan, R., Peters, L. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231205 · Cited by 1,365
The retinoids—Biology, chemistry and medicine
(1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)80793-5 · Cited by 1,178
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Embryonic retinoic acid synthesis is essential for early mouse post-implantation development
Niederreither, K., Subbarayan, V., Dollé, P., & Chambon, P. (1999) · Nature Genetics · doi:10.1038/7788 · Cited by 1,077
Role of the histone deacetylase complex in acute promyelocytic leukaemia
Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., & Evans, R. M. (1998) · Nature · doi:10.1038/35895 · Cited by 1,062 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
BackgroundGrignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., et al. (1998) · Nature · doi:10.1038/35901 · Cited by 1,004 · cited 1×
“However, high concentrations of HDAC inhibitors (HDACi) can convert even PLZF–RARα into an activator of the RA signalling pathwa”
Background
Research works printed but not linked: 1
- Moon, R. C., Mehta, R. G. & Rao, K. J. V. N. in The Retinoids (eds Sporn, M. B., Roberts, A. B. & Goodman, D. S.) 573–595 (Raven, New York, 1994).
Cited by
Items 501–600 of 784
Savickienė, J., Treigytė, G., Magnusson, K., & Navakauskienė, R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.002 · Cited by 12
Grunt, T. W., Tomek, K., Wagner, R., Puckmair, K., Kainz, B., Rünzler, D., Gaiger, A., Köhler, G., & Zielinski, C. C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20990 · Cited by 12
RETRACTED: Identification and characterization of GRIM-1, a cell-death-associated gene product
Hofmann, E. R., Nallar, S. C., Lin, L., Lindner, D. J., Weihua, X., & Kalvakolanu, D. V. (2010) · Journal of Cell Science · doi:10.1242/jcs.070250 · Cited by 11
“Retinoids inhibit growth of certain leukemias, skin dysplasias in vivo and tumor cell lines in vitro (Altucci and Gronemeyer, 2001).”
BackgroundRetractedBiological Activities of Carotenoid Metabolites
Wang, X. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7501-0_18 · Cited by 12
Kanemura, N., Tsurumi, H., Okuno, M., Matsushima‐Nishiwaki, R., Shimizu, M., & Moriwaki, H. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.11.005 · Cited by 11
“[4] Altucci L, Gronemeyer H.”
BackgroundInfluentialImpact of Preferentially Expressed Antigen of Melanoma on the Prognosis of Hepatocellular Carcinoma
Oyama, K., Kanki, K., Shimizu, H., Kono, Y., Azumi, J., Toriguchi, K., Hatano, E., & Shiota, G. (2016) · Gastrointestinal Tumors · doi:10.1159/000448137 · Cited by 11
Imajo, M., Kondoh, K., Yamamoto, T., Nakayama, K., Nakajima‐Koyama, M., & Nishida, E. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00012-17 · Cited by 12
“It should be noted that treatment with pharmacological doses of retinoids, which results in the activation of RAR signaling, has been considered a promising strategy for cancer therapy and prevention (3, 4, 8).”
BackgroundMiyajima, N., Watanabe, M., Ohashi, E., Mochizuki, M., Nishimura, R., Ogawa, H., Sugano, S., & Sasaki, N. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb02867.x · Cited by 11
Shimizu, M., Shirakami, Y., Hanai, T., Imai, K., Suetsugu, A., Takai, K., Shiraki, M., & Moriwaki, H. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300538 · Cited by 11
Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2
Kitagawa, J., Hara, T., Tsurumi, H., Ninomiya, S., Ogawa, K., Adachi, S., Kanemura, N., Kasahara, S., Shimizu, M., & Moriwaki, H. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0938-0 · Cited by 11
“Retinoic acids (RAs), a group of structural and functional analogs of vitamin A, exert fundamental eVects on the regulation of epithelial cell growth, proliferation, diVerentiation, and development (Altucci and Gronemeyer 2001; Chmbon 1996).”
BackgroundInfluentialRetinoic acid via RARα inhibits the expression of 24-hydroxylase in human prostate stromal cells
Lou, Y., Miettinen, S., Kagechika, H., Gronemeyer, H., & Tuohimaa, P. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.178 · Cited by 11
“Retinoic acid (RA), the most potent form of vitamin A, also plays an important role in the growth and differentiation of many cells [13].”
BackgroundSelf-citationDesign and synthesis of (E)-4-((3-ethyl-2,4,4-trimethylcyclohex-2-enylidene)methyl)benzoic acid
Das, B. C., & Kabalka, G. W. (2008) · Tetrahedron Letters · doi:10.1016/j.tetlet.2008.05.136 · Cited by 11
Samuel, S., & Bernstein, L. R. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10163 · Cited by 11
Retinoid acid receptors in human colorectal cancer: An unexpected link with patient outcome
Perraud, A., Nouaille, M., Akil, H., Petit, D. P., Labrousse, F., Jauberteau, M., & Mathonnet, M. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.242 · Cited by 13
“…complex binds to the retinoic acid response element sequence, located near the promoter of target genes, to induce or inhibit transcription (3). the rar family comprises three members: α , β and γ . rar β expression is frequently reduced in tumor cells, probably due to the hypermethylation…”
InfluentialMurine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents
Patel, J. B., Khandelwal, A., Chopra, P., Handratta, V. D., & Njar, V. C. O. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0438-3 · Cited by 11
Xie, L., Song, Y., Lin, T.-F., Guo, H., Wang, B., Tang, G., Liu, C., Huang, W., Yang, Y., Ling, W., et al. (2019) · British Journal Of Nutrition · doi:10.1017/s000711451900120x · Cited by 11
“In animal models, vitamin A may suppress carcinogenesis(4,6).”
BackgroundFerlosio, A., Doldo, E., Agostinelli, S., Costanza, G., Centofanti, F., Sidoni, A., & Orlandi, A. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05744-5 · Cited by 11
Li, W., Gong, H., Fu, Y., Sun, J., & Wang, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112838 · Cited by 11
Vitamin A and the immune system
Ross, A. C., & Restori, K. H. (2013) · Elsevier eBooks · doi:10.1533/9780857095749.2.221 · Cited by 14
Retinoids and retinoic acid receptor in cancer
Lei, M., & de Thé, H. (2003) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(03)00010-7 · Cited by 12
“A flurry of reviews have addressed the issues of retinoid biosynthesis, nuclear receptor function and links to cancer [1].”
BackgroundÖzpolat, B., Akar, U., Tekedereli, İ., Alpay, S. N., Barria, M., Gezgen, B., Zhang, N., Coombes, K. R., Kornblau, S. M., & Lopez‐Berestein, G. (2012) · Leukemia Research and Treatment · doi:10.1155/2012/482905 · Cited by 10
“The success of ATRA in the treatment of APL introduced the concept of differentiation therapy in treating malignant diseases [1].”
BackgroundTheus, M. H., Sparks, J. B., Liao, X., Ren, J., & Luo, X. (2016) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155416679638 · Cited by 10
“tRA regulates a broad range of systemic processes through retinoic acid (RA) receptors, including RAR-α, RAR-β, and RAR-γ, which are structurally and functionally related to glucocorticoid receptors.(24) Gut-specific CD103 dendritic cells secrete tRA, which modulates the T helper (Th)17-regulatory T cell (Treg) balanc…”
BackgroundDesign, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists
Guan, X., Luo, P., He, Q., Hu, Y., & Ying, H. (2016) · Molecules · doi:10.3390/molecules22010032 · Cited by 10
RAR α/ RXR synergism potentiates retinoid responsiveness in cutaneous T‐cell lymphoma cell lines
Wang, L., DeMarco, S. S., Peaks, M. S., Maiorana-Boutilier, A., Chen, J., Crouch, M. J., Shewchuk, B. M., Shaikh, S. R., Phillips, C. M., & Bridges, L. C. (2017) · Experimental Dermatology · doi:10.1111/exd.13348 · Cited by 10
Pinello, K. C., Nagamine, M. K., da Silva, T. C., Matsuzaki, P., Caetano, H. V. A., Torres, L. N., Fukumasu, H., Avanzo, J. L., Matera, J. M., & Dagli, M. L. (2009) · Veterinary Research Communications · doi:10.1007/s11259-008-9202-3 · Cited by 14
“…therapies need to be improved in order to obtain a better prognosis in undifferentiated MCTs. Retinoids are active metabolites of vitamin A and modulate various biological functions such as cell differentiation, proliferation and embryonic development in vertebrates (Altucci and Gronemeyer 2001).”
BackgroundA phase 1 study of tazarotene in adults with advanced cancer
Jones, P. H., Burnett, R. D., Fainaru, I., Nadolny, P., Walker, P., Yu, Z., Tang-Liu, D. D.-S., Ganesan, T. S., Talbot, D. C., Harris, A. L., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601169 · Cited by 10
“The improved tolerance of tazarotene may be due to its selective activity on RARb and RARg receptors, in contrast to ATRA which is a pan RAR agonist and 9-Cis RA which is a pan RAR and RXR agonist (Altucci and Gronemeyer, 2001).”
BackgroundInfluentialWu, Y., Mou, Z., Li, J., Zhou, W., Wei, B., & Zou, L. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00211-x · Cited by 10
Adamantyl Arotinoids That Inhibit IκB Kinase α and IκB Kinase β
Lorenzo, P., Ortiz, M. A., Álvarez, R., Piedrafita, F. J., & de Lera, Á. R. (2013) · ChemMedChem · doi:10.1002/cmdc.201300100 · Cited by 10
Cañestro, C., Albalat, R., & Postlethwait, J. H. (2010) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.27.128 · Cited by 10
“Disruption of RA action leads to human pathologies, including embryo defects and cancer (Altucci and Gronemeyer, 2001).”
BackgroundAlcohol and Retinoid Interaction
Wang, X. D., Seitz, H. K., WATSON, R. R., & Preedy, V. R. (2004) · doi:10.1201/9780203507636-29 · Cited by 10
Arce, J. D.-C., Soto, U., van Riggelen, J., Schwarz, E., Hausen, H. Z., & Rösl, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401818200 · Cited by 10
9-cis-Retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists
Álvarez, R., Vega, M. J., Kammerer, S., Rossin, A., Germain, P., Gronemeyer, H., & de Lera, Á. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.072 · Cited by 10
Self-citationLiu, Z., & Zheng, Y. (2024) · Discovery Medicine · doi:10.24976/discov.med.202436184.97 · Cited by 10
Harnessing nutrients and natural products for sustainable drug development against aging
Ding, F., Yu, Y., Zhang, Y., Wei, S., Han, J. H., Li, Z., Jiang, H., Ryu, D., Park, W., Ha, K., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1579266 · Cited by 11
Agboyibor, C., Dong, J., Effah, C. Y., Drokow, E. K., Ampomah‐Wireko, M., Pervaiz, W., Sangmor, A., Ma, X., Li, J., Liu, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113934 · Cited by 10
Carotenoids and lung cancer prevention
Veeramachaneni, S. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e25 · Cited by 14
Alfonso, H. S., Fritschi, L., de Klerk, N. H., Ambrosini, G. L., Beilby, J. P., Olsen, N. J., & Musk, A. W. (2006) · European Journal of Cancer Prevention · doi:10.1097/00008469-200608000-00003 · Cited by 9
“Other possible mechanisms include effects on the way cells multiply and differentiate (Niles, 2000; Yoshimi et al., 2000; Altucci and Gronemeyer, 2001).”
BackgroundThe ETS Family Member TEL Binds to Nuclear Receptors RAR and RXR and Represses Gene Activation
Meester‐Smoor, M. A., Janssen, M. J. F. W., ter Haar, W. M., van Wely, K. H. M., Aarnoudse, A. L. H. J., van Oord, G. W., van Tilburg, G. B. A., & Zwarthoff, E. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023620 · Cited by 10
“retinoic acid (ATRA). RAR-signaling induces differentiation and apoptosis in a wide variety of cells. Furthermore, retinoic acid has tumor-suppressive activity and defects in RAR signaling are implicated in cancers”
BackgroundCarlson, L.-M., Påhlman, S., Geer, A. D., Kogner, P., & Levitskaya, J. (2008) · Cell Research · doi:10.1038/cr.2008.27 · Cited by 9
Retinoid Therapy for Autoimmune Diseases
Fukasawa, H., Kagechika, H., & Shudo, K. (2006) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.29.114 · Cited by 10
Structural changes of β-carotene and some retinoid pharmaceuticals induced by environmental factors
Roman, M., Kaczor, A., Dobrowolski, J. C., & Barańśka, M. (2012) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2012.12.038 · Cited by 9
Anticancer Drugs That Modulate Hormone Action
Avendaño, C., & Menéndez, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-444-62649-3.00003-x · Cited by 18
Molecular Imaging of Retinoic Acids in Live Cells Using Single-Chain Bioluminescence Probes
Kim, S. B., Fujii, R., Nishihara, R., Bose, R. J., Citterio, D., Suzuki, K. A. O., Massoud, T. F., & Paulmurugan, R. (2019) · ACS Combinatorial Science · doi:10.1021/acscombsci.9b00035 · Cited by 9
Liu, L., Derguini, F., & Gudas, L. J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21824 · Cited by 9
“…and various other synthetic retinoids act via binding and activating nuclear receptors, the retinoic acid receptors and retinoid X receptors, which are transcription factors that directly regulate the transcription of certain ‘‘target’’ genes (Altucci and Gronemeyer, 2001; Mongan and Gudas, 2007).”
BackgroundTsujino, T., Nagata, T., Katoh, F., & Yamasaki, H. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2007.06.001 · Cited by 9
“Since RAR acts as a receptor for NIK-333 and ATRA and RXR is also a receptor of NIK-333 [5], it is not surprising that this cell line responded to NIK-333 and ATRA.”
BackgroundInfluentialSon, S., Yu, E., Ahn, Y., Choi, E. K., Lee, H., & Choi, J. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.04.005 · Cited by 9
“Recent studies have reported the potential of RAs as therapeutic agents for the treatment of various cancers [2,3].”
BackgroundHan, H., Kwon, Y., Park, S., Kim, E., Rho, Y., Sin, H., & Um, S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11643 · Cited by 9
Thomas, M. A., Hodgson, M. C., Loermans, S. D., Hooper, J., Endersby, R., & Bentel, J. M. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21020 · Cited by 16
“Retinoids, analogs of vitamin A, are well known to play highly diverse roles in both developmentand cell homeostasis through their regulatory effects on target genes involved in processes such as cell proliferation, differentiation, and apoptosis [Ross et al., 2000; Altucci and Gronemeyer, 2001].”
BackgroundCanney, D. J., Sun, W., Desai, S., Piao, H., & Carroll, P. J. (2007) · Heterocycles · doi:10.3987/com-06-10955 · Cited by 9
REIFENBERGER, J. (2004) · Der Hautarzt · doi:10.1007/s00105-004-0800-x · Cited by 12
Garattini, S. K., Basile, D., Re, V. D., Brisotto, G., Miolo, G., Canzonieri, V., Aprile, G., Corvaja, C., Buriolla, S., Garattini, E., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1453934 · Cited by 8
Chen, F., Cai, Y., & Zhou, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-02295-8 · Cited by 10
“Extensive studies have demonstrated the inhibitory effects of retinol on various tumor types including breast cancer, skin cancer, lung cancer, and prostate cancer [17].”
Potential of fat-soluble vitamins as a platform for antiviral drug development
Hirota, Y., Okamoto, M., Baba, M., & Suhara, Y. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130292 · Cited by 8
Design and synthesis of boron containing potential pan-RAR inverse agonists
Das, B. C., Tang, X., & Evans, T. (2012) · Tetrahedron Letters · doi:10.1016/j.tetlet.2011.12.118 · Cited by 8
Bohn, T., Hellmann‐Regen, J., de Lera, Á. R., Böhm, V., & Rühl, R. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00750-3 · Cited by 9
“…™ , Adapalene ™ , Tazarotene ™ and Trifarotene ™ have been employed for systemic and/or local treatment of cancer or dermatological disorders [19–23]. β-Carotene is the most abundant provitamin A carotenoid in the human diet, and is used as a coloring agent, as an antioxidant and as a…”
BackgroundThe tumor microenvironment as a target for anticancer treatment
Bizzarri, M., Cucina, A., & Proietti, S. (2014) · Oncobiology and Targets · doi:10.4103/2395-4469.145341 · Cited by 8
Tsai, Y.-J., Wu, S.-Y., Huang, H., Ma, D. H. K., Wang, N., Hsiao, C., Cheng, C., & Yeh, L. (2015) · BMC Ophthalmology · doi:10.1186/s12886-015-0145-5 · Cited by 9
Hennig, D., Müller, S., Wichmann, C. W., Drube, S., Pietschmann, K., Pelzl, L., Grez, M., Bug, G., Heinzel, T., & Krämer, O. H. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.589 · Cited by 10
“Others reported similar findings (Altucci and Gronemeyer, 2001; Côté et al, 2002; Fazi et al, 2005).”
BackgroundResultMasood, S. (2015) · The Breast Journal · doi:10.1111/tbj.12362 · Cited by 8
“dures such as fine-needle aspiration, DL, and nipple aspirate fluid (34,42).”
BackgroundGhandour, B., Pisano, C., Darwiche, N., & Dbaibo, G. S. (2020) · Bioscience Reports · doi:10.1042/bsr20200050 · Cited by 8
“regulate hematopoietic cell proliferation and differentiation [1-4] .”
Human NCU-G1 can function as a transcription factor and as a nuclear receptor co-activator
Steffensen, K. R., Bouzga, M. M., Skjeldal, F. M., Kasi, C., Karahasan, A., Matre, V., Bakke, O., Guérin, S. L., & Eskild, W. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-106 · Cited by 13
“Malfunction of vitamin A regulated genes have been described in various cancer types [3-5].”
Ivanova, D. I., Gaudon, C., Rossin, A., Bourguet, W., & Gronemeyer, H. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00083-4 · Cited by 8
Self-citationSalih, H. R., & Kiener, P. A. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000139684 · Cited by 8
“metabolites and synthetic retinoids have been identified and investigated in experimental settings [8].”
BackgroundGoelden, U., Pfoertner, S., Hansen, W., Toepfer, T., von Knobloch, R., Hofmann, R. W., Buer, J., & Schrader, A. J. (2005) · Urologia Internationalis · doi:10.1159/000087807 · Cited by 11
An immature subset of neuroblastoma cells synthesizes retinoic acid and depends on this metabolitePreprint
van Groningen, T., Niklasson, C. U., Chan, A., Akogul, N., Westerhout, E. M., von Stedingk, K., Hamdi, M., Valentijn, L. J., Mohlin, S., Stroeken, P. J. M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.18.444639 · Cited by 11
Davis, E., Ermi, A. G., & Sarkar, D. (2025) · Cancers · doi:10.3390/cancers17081375 · Cited by 7
“Retinoic acid Thus, in HCC cells, there are multiple mechanisms by which AEG-1 inhibits RXR function. is known for its anti-cancer properties [114] and its receptor RAR regulates gene transcription by Retinoic acid is known for its anti-cancer properties [114] and its receptor RAR regulates gene…”
Mechanistic insights on anticancer drugs with specific biological targets and signalling pathways
Patwekar, M., Patwekar, F. I., Medikeri, A., Daniyal, S., Kamal, M. A., Rather, G. A., & Sharma, R. (2023) · Exploration of Medicine · doi:10.37349/emed.2023.00166 · Cited by 11
Ozgun, G., Yaraş, T., Akman, B., Özden-Yılmaz, G., Landman, N., Karakülah, G., van Lohuizen, M., Şentürk, Ş., & Erkek, S. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00725-3 · Cited by 9
Ye, T., Jiang, B., Chen, B., Liu, X., Yang, L., Xiong, W., & Yu, B. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101887 · Cited by 7
Sur, D. G., Gorzo, A., Sabarimurugan, S., Krishnan, S. M., Lungulescu, C. V., Volovăț, S. R., & Burz, C. C. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210901100827 · Cited by 9
Davis, C. P., Garzia, N. A., Cushing‐Haugen, K. L., Terry, K. L., Chiu, Y., Sandoval‐Insausti, H., Chavarro, J. E., Missmer, S. A., & Harris, H. R. (2022) · F&S Science · doi:10.1016/j.xfss.2022.12.001 · Cited by 11
Application of retinoids in the treatment of renal cell carcinoma–a futile effort?
Schrader, A. J., von Knobloch, R., Heidenreich, A., Buer, J., & Hofmann, R. W. (2004) · Anti-Cancer Drugs · doi:10.1097/00001813-200410000-00001 · Cited by 8
Zafar, S. F., Nagaraju, G. P., & El‐Rayes, B. F. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.691473 · Cited by 8
“Furthermore, RaR have been found to be epigenetically silenced in epithelial cancers [66].”
BackgroundAlfonso, H. S., Fritschi, L., de Klerk, N. H., Ambrosini, G. L., Beilby, J. P., Olsen, N. J., & Musk, A. W. (2005) · Journal of Occupational and Environmental Medicine · doi:10.1097/01.jom.0000165750.54747.27 · Cited by 7
“Retinol has a variety of effects on the cell membrane, involving altered glycoprotein synthesis and changes in membrane receptors for various hormones, including those mediated by c-AMP.(27,28) The actions on these receptors may influence cell–cell interactions, cell adhesion, and cell membrane permeability.”
BackgroundMulvihill, M. J., Kan, J. L. C., Cooke, A. R., Bhagwat, S. S., Beck, P., Bittner, M., Cesario, C., Keane, D. M., Lazarescu, V., Nigro, A., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.020 · Cited by 8
Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review
Marchwicka, A., Cunningham, A., Marcinkowska, E., & Brown, G. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1205586 · Cited by 7
“It has been shown that RARs trigger differentiation, cell cycle arrest, and apoptosis [15], while PPAR β/δ promotes cell survival and proliferation [16,17].”
BackgroundRetinoic Acid Binding Proteins and Cancer: Similarity or Polarity?
Tchevkina, E. M. (2017) · Cancer therapy & Oncology International Journal · doi:10.19080/ctoij.2017.08.555733 · Cited by 7
“At present an active attempts are being made to use RA and its derivatives in the therapy of malignant neoplasms [1-5].”
BackgroundFrancesco, A. M. D., Ubezio, P., Torella, A. R., Meco, D., Pierri, F., Barone, G., Cusano, G., Pisano, C., D’Incalci, M., & Riccardi, R. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9689-2 · Cited by 9
“In conclusion, in this report we provide lines of evidence that the novel retinoid ST1926 potentiates the action of ATRA-based treatment in neuroblastoma models, supporting the idea that such a combination can result in improved antitumour activity, allowing the use of lower retinoid concentrations with potentially re…”
BackgroundQin, S., Okawa, Y., Atangan, L. I., Brown, G., Chandraratna, R. A. S., & Zhao, Y. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.08.001 · Cited by 8
Apoptotic and anti-proliferative effects of all-trans retinoic acid.
Zamora, M., Ortega, J. A., Alaña, L., Viñas, O., & Mampel, T. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.02.014 · Cited by 11
Retinoids for preventing the progression of cervical intra-epithelial neoplasia
Helm, C. W., Lorenz, D. J., Meyer, N. J., Rising, W., & Wulff, J. L. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003296.pub2 · Cited by 7
Dahiya, N. R., Leibovitch, B. A., Kadamb, R., Bansal, N., & Waxman, S. (2022) · Cells · doi:10.3390/cells11071179 · Cited by 6
“Retinoids have been studied for their chemo-preventive effect in solid tumors such as head and neck cancers [5], hepatocellular carcinomas, lung cancer [6], breast cancer and differentiation therapy for acute promyelocytic leukemia (APL) [7–9].”
BackgroundNiu, S., Shi, K., Yue, X., Pan, M., Song, L., Gu, L., Tan, Y., Miao, X., Tian, J., & Chang, J. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23540 · Cited by 6
Jarczewska, K., Kopeć, M., Abramczyk, H., & Surmacki, J. M. (2024) · RSC Advances · doi:10.1039/d4ra01542h · Cited by 6
A convenient synthesis of new NSAID esters containing amino acid, urea and amide moieties
Perković, I., Džolić, Z. R., & Zorc, B. (2013) · Acta Pharmaceutica · doi:10.2478/acph-2013-0023 · Cited by 6
Takeda, K., Takahashi, N.-H., Yoshizawa, M., & Shibahara, S. (2010) · The Journal of Biochemistry · doi:10.1093/jb/mvq040 · Cited by 6
Dual RXR Agonists and RAR Antagonists Based on the Stilbene Retinoid Scaffold
Martínez, C., Lieb, M., Álvarez, S., Rodríguez‐Barrios, F., Álvarez, R., Khanwalkar, H., Gronemeyer, H., & de Lera, Á. R. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400521f · Cited by 7
Self-citationIdeta, T., Shirakami, Y., Ohnishi, M., Maruta, A., Obara, K., Miyazaki, T., Kochi, T., Sakai, H., Tomita, H., Tanaka, T., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19978 · Cited by 6
“Retinoids are known as key modulators for energy metabolism [10], and the relationship between retinoid abnormalities and liver carcinogenesis has been reported widely [25, 26].”
BackgroundDysregulatory effects of retinoic acid isomers in late zebrafish embryos
Navarro‐Martín, L., Oliveira, E., Casado, M., Barata, C., & Piña, B. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-0732-5 · Cited by 7
High Expression of RARβ Is a Favorable Factor in Colorectal Cancer
Wang, W., Liu, S., Jiang, C., Wang, Y., Zhu, H., & Wang, X. (2019) · Disease Markers · doi:10.1155/2019/7138754 · Cited by 6
“Collectively, one of the most important functions of retinoids is their antitumor activity, including the inhibition of tumor growth and the promotion of apoptosis, which has led to their function as chemotherapeutic agents [11, 27].”
BackgroundCarlsen, H., Ebihara, K., Kuwata, N. H., Kuwata, K., Aydemir, G., Rühl, R., & Blomhoff, R. (2021) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000705 · Cited by 8
Catalytic synthesis of 9- cis -retinoids: mechanistic insights
Kahremany, S., Kubas, A., Tochtrop, G. P., & Palczewski, K. (2019) · Dalton Transactions · doi:10.1039/c9dt02189b · Cited by 6
Induction of murine leukemia and lymphoma by dominant negative retinoic acid receptor α
Wang, Y., Shen, K. C., Ishida, Y., Wang, Y., Kakizuka, A., & Brooks, S. C. (2005) · Molecular Carcinogenesis · doi:10.1002/mc.20144 · Cited by 6
Karamouzis, M. V., Sotiropoulou‐Bonikou, G., Vandoros, G. P., Varakis, I., & Papavassiliou, A. G. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00346-x · Cited by 6
“Several lines of evidence indicate that RAR/RXR heterodimers are the functional units transducing the retinoid signal [22].”
BackgroundGrunt, T. W., Tomek, K., Wagner, R., Puckmair, K., & Zielinski, C. C. (2007) · Differentiation · doi:10.1111/j.1432-0436.2007.00199.x · Cited by 6
Association of retinoids, retinoic acid receptors and epigenetics in breast cancer
Szymański, Ł., Schenk, T., Ławiński, M., Brioli, A., & Zelent, A. (2026) · Oncogene · doi:10.1038/s41388-026-03699-8 · Cited by 5
Retinoic acids in oral precancer: Utility and challenges
Pandey, R. K., & Mehrotra, D. (2020) · Journal of Oral and Maxillofacial Surgery Medicine and Pathology · doi:10.1016/j.ajoms.2020.04.001 · Cited by 6
Wen, Y., Yang, X., & Huang, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561251 · Cited by 5
“According to epidemiological research, the more vitamin A you take in through your diet, the less likely you are to develop cancer (27–29).”
Todaro, L. B., Veloso, M. J., Campodónico, P. B., Puricelli, L., Farias, E., & Joffé, E. B. D. K. (2012) · Breast Cancer · doi:10.1007/s12282-012-0342-5 · Cited by 6
“Much evidence supports the notion that RA can interfere with oncogenesis, impairing tumor development and tumor growth [15].”
BackgroundShimizu, M., Shirakami, Y., Sakai, H., Iwasa, J., Shiraki, M., Takai, K., Naiki, T., & Moriwaki, H. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01045.x · Cited by 5
Metadata
- Authors
- Altucci, L., & Gronemeyer, H.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Venue
- Nature Reviews Cancer
- Published
- 2001-12
- Volume
- 1
- Issue
- 3
- Pages
- 181-193
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1964224609
- Cited by
- 773
- References
- 147
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 16 · 2023: 18 · 2022: 12 · 2021: 16 · 2020: 20 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 25 · 2015: 36 · 2014: 25 · 2013: 32 · 2012: 47
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- Funders
- Bristol-Myers Squibb
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- retinoids, cancer therapy, cancer prevention, tumor suppression, antiproliferative mechanism, teratogenicity, cell proliferation
- MeSH terms
- Antineoplastic Agents, Cell Differentiation, Forecasting, Humans, Models, Biological, Morphogenesis, Neoplasm Proteins, Neoplasms, Retinoids, Skin Neoplasms, Structure-Activity Relationship, Vitamin A, Leukemia, Promyelocytic, Acute, Oncogene Proteins, Fusion, Transcriptional Activation, Gene Expression Regulation, Neoplastic, Anticarcinogenic Agents, Apoptosis, Receptors, Retinoic Acid, Transcription Factor AP-1, Dimerization, Receptor Cross-Talk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.